Shaimaa Mostafa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shaimaa Mostafa has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Al-Shimaa Mohamed Sabry
Department of Cardiology, Benha University Hospital, Faculty of Medicine, Benha University, Benha, Egypt
3 shared publications - Shereen Ibrahim Farag
Benha University
2 shared publications - A. М. Abdelmoneim
Benha univerisity
1 shared publication Ahmed Azam
Cardiovascular Department, El-Agoza Police Hospital, Giza, Egypt
1 shared publicationAlaa Galal
Department of Cardiology, Benha Faculty of Medicine, Benha University, and National Heart Institute, Egypt
1 shared publication- Aldo Pietro Maggioni
Centro Studi ANMCO—Heart Care Foundation, 50121 Florence, Italy
1 shared publication
Latest Publications
- Open Access
- 28 October 2026
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 22 (4) , 320-326
Association of the low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and non-high-density lipoprotein cholesterol with the severity of coronary artery disease in patients with chronic coronary syndrome
Aim. Тo assess the association and discriminatory performance of the low-density lipoprotein cholesterol to high-density lipoprotein cholesterol (LDL-C/HDL-C) ratio and non-HDL-C in relation to coronary artery disease (CAD) severity in patients with chronic coronary syndrome (CCS). Material and methods. This multicenter, cross-sectional study included 500 adult patients diagnosed with CCS who underwent coronary angiography. Patients were stratified into two groups according to SYNTAX score: a high SYNTAX score group (≥33; n=149) and a low-to-intermediate group (2.3 yielded a sensitivity of 58.39% and specificity of 96.58%, with PPV of 87.9% and NPV of 84.5%. For non-HDL-C, a cutoff value >2.48 mmol/L provided 73.15% sensitivity and specificity, with PPV of 45.6% and NPV of 84.7%. Conclusion. Both the LDL-C/HDL-C ratio and non-HDL-C are significantly associated with the severity of coronary artery disease in patients with CCS. The LDL-C/HDL-C ratio demonstrated favorable discriminatory ability and may serve as a useful adjunctive marker for the assessment of CAD severity in patients with CCS.
- 28 October 2026
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 22 (4) , 320-326
Open AccessAssociation of the low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and non-high-density lipoprotein cholesterol with the severity of coronary artery disease in patients with chronic coronary syndrome
Aim. Тo assess the association and discriminatory performance of the low-density lipoprotein cholesterol to high-density lipoprotein cholesterol (LDL-C/HDL-C) ratio and non-HDL-C in relation to coronary artery disease (CAD) severity in patients with chronic coronary syndrome (CCS). Material and methods. This multicenter, cross-sectional study included 500 adult patients diagnosed with CCS who underwent coronary angiography. Patients were stratified into two groups according to SYNTAX score: a high SYNTAX score group (≥33; n=149) and a low-to-intermediate group (2.3 yielded a sensitivity of 58.39% and specificity of 96.58%, with PPV of 87.9% and NPV of 84.5%. For non-HDL-C, a cutoff value >2.48 mmol/L provided 73.15% sensitivity and specificity, with PPV of 45.6% and NPV of 84.7%. Conclusion. Both the LDL-C/HDL-C ratio and non-HDL-C are significantly associated with the severity of coronary artery disease in patients with CCS. The LDL-C/HDL-C ratio demonstrated favorable discriminatory ability and may serve as a useful adjunctive marker for the assessment of CAD severity in patients with CCS.
- Open Access
- 1 March 2024
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 45 (16) , 1443-1454
Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry
Childhood-onset cardiomyopathies are rare and poorly characterized. This study examined the baseline characteristics and 1-year follow-up of children with cardiomyopathy in the first European Cardiomyopathy Registry. Prospective data were collected on individuals aged 1–n = 388 (61.3%)], dilated [DCM; n = 206 (32.5%)], restrictive [RCM; n = 28 (4.4%)], and arrhythmogenic right ventricular cardiomyopathy [ARVC; n = 11 (1.7%)] were enrolled by 23 referral centres in 14 countries. Median age at diagnosis was 4.0 [interquartile range (IQR) 0–10] years, and there was a male predominance [n = 372 (58.8%)] across all subtypes, with the exception of DCM diagnosed P = .003]. Over a median follow-up of 12.5 months (IQR 11.3–15.3 months), 18 patients (3.3%) died [HCM n = 9 (2.6%), DCM n = 5 (3.0%), RCM n = 4 (16.0%)]. Heart failure events were most frequent in RCM patients (36.0%). The findings confirm the heterogeneous aetiology of childhood cardiomyopathies and show a high frequency of familial disease. Outcomes differed by cardiomyopathy subtype, highlighting a need for disease-specific evaluation and treatment. Characteristics and outcomes of paediatric onset cardiomyopathy in a European population. HCM, hypertrophic cardiomyopathy; DCM, dilated cardiomyopathy; RCM, restrictive cardiomyopathy; ARVC, arrhythmogenic right ventricular cardiomyopathy.
- 1 March 2024
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 45 (16) , 1443-1454
Open AccessCardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry
Childhood-onset cardiomyopathies are rare and poorly characterized. This study examined the baseline characteristics and 1-year follow-up of children with cardiomyopathy in the first European Cardiomyopathy Registry. Prospective data were collected on individuals aged 1–n = 388 (61.3%)], dilated [DCM; n = 206 (32.5%)], restrictive [RCM; n = 28 (4.4%)], and arrhythmogenic right ventricular cardiomyopathy [ARVC; n = 11 (1.7%)] were enrolled by 23 referral centres in 14 countries. Median age at diagnosis was 4.0 [interquartile range (IQR) 0–10] years, and there was a male predominance [n = 372 (58.8%)] across all subtypes, with the exception of DCM diagnosed P = .003]. Over a median follow-up of 12.5 months (IQR 11.3–15.3 months), 18 patients (3.3%) died [HCM n = 9 (2.6%), DCM n = 5 (3.0%), RCM n = 4 (16.0%)]. Heart failure events were most frequent in RCM patients (36.0%). The findings confirm the heterogeneous aetiology of childhood cardiomyopathies and show a high frequency of familial disease. Outcomes differed by cardiomyopathy subtype, highlighting a need for disease-specific evaluation and treatment. Characteristics and outcomes of paediatric onset cardiomyopathy in a European population. HCM, hypertrophic cardiomyopathy; DCM, dilated cardiomyopathy; RCM, restrictive cardiomyopathy; ARVC, arrhythmogenic right ventricular cardiomyopathy.
- Open Access
- 26 February 2024
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 20 (1) , 13-18
Clinical, electrical, and functional changes following CRT-P implantation: short-term results in patients with non-ischaemic cardiomyopathy
Aim. Assessment of the correlation between cardiac remodeling, functional status and electrical remodeling after cardiac resynchronisation therapy (CRT) in patients with non-ischaemic cardiomyopathy.Material and methods. A single center, prospective, observational study included 50 patients with non-ischaemic cardiomyopathy who were candidate for CRT implantation. All patients prior to CRT and then 3 months after implantation had standard 12-lead surface ECGs to assess QRSd for assessment electrical response, for assessment of left ventricular ejection fraction (LVEF) and volumes (left ventricular end diastolic and systolic volume, LVEDV and LVESV), mitral regurgitation (degree of mitral regurgitation), pulmonary artery systolic pressure (for diagnosis of pulmonary hypertension), NYHA class and 6 minute walk test (6MWT) to assess patient’s functional capacity.Results. 50 patients with CRT were included (35 males and 15 females, mean age 54.88±7.48 years). All patients were in sinus rhythm with QRS duration (QRSd) ≥120 ms, EFConclusion. The CRT-pacemaker implantation was associated with significant improvement in QRSd, NYHA class, 6MWT and LV volumes in the short-term period. QRSd improvement was significantly correlated with functional status and LV EF.
- 26 February 2024
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 20 (1) , 13-18
Open AccessClinical, electrical, and functional changes following CRT-P implantation: short-term results in patients with non-ischaemic cardiomyopathy
Aim. Assessment of the correlation between cardiac remodeling, functional status and electrical remodeling after cardiac resynchronisation therapy (CRT) in patients with non-ischaemic cardiomyopathy.Material and methods. A single center, prospective, observational study included 50 patients with non-ischaemic cardiomyopathy who were candidate for CRT implantation. All patients prior to CRT and then 3 months after implantation had standard 12-lead surface ECGs to assess QRSd for assessment electrical response, for assessment of left ventricular ejection fraction (LVEF) and volumes (left ventricular end diastolic and systolic volume, LVEDV and LVESV), mitral regurgitation (degree of mitral regurgitation), pulmonary artery systolic pressure (for diagnosis of pulmonary hypertension), NYHA class and 6 minute walk test (6MWT) to assess patient’s functional capacity.Results. 50 patients with CRT were included (35 males and 15 females, mean age 54.88±7.48 years). All patients were in sinus rhythm with QRS duration (QRSd) ≥120 ms, EFConclusion. The CRT-pacemaker implantation was associated with significant improvement in QRSd, NYHA class, 6MWT and LV volumes in the short-term period. QRSd improvement was significantly correlated with functional status and LV EF.
- Open Access
- 13 July 2021
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 17 (3) , 438-443
The Effect of Clinical Characteristics and Stent Parameters on Left Ventricular Mechanical Dyssynchrony
Aim. To study short term effect of stent size and number on left ventricular mechanical dyssynchrony after elective percutaneous coronary intervention (PCI) to left anterior descending (LAD) artery.Materials and methods. the study included 150 adult patients with LAD lesion treated with PCI using drug-eluting stent. Patients were evaluated pre PCI then 1 month and 3 months post PCI for evaluation of mechanical dyssynchrony using tissue synchronization image (TSI).Results. Before revascularization mean left ventricular ejection fraction was 51.2±5.7 %, mean time to peak TSI was 213.6±10.9 ms; 1 month after PCI TSI improved significantly to 163.7±17.6 ms (pConclusion. Increased number and length of the implanted stents were predictors to non-improvement of mechanical dyssynchrony, while stent diameter didn’t affects the recovery.
- 13 July 2021
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 17 (3) , 438-443
Open AccessThe Effect of Clinical Characteristics and Stent Parameters on Left Ventricular Mechanical Dyssynchrony
Aim. To study short term effect of stent size and number on left ventricular mechanical dyssynchrony after elective percutaneous coronary intervention (PCI) to left anterior descending (LAD) artery.Materials and methods. the study included 150 adult patients with LAD lesion treated with PCI using drug-eluting stent. Patients were evaluated pre PCI then 1 month and 3 months post PCI for evaluation of mechanical dyssynchrony using tissue synchronization image (TSI).Results. Before revascularization mean left ventricular ejection fraction was 51.2±5.7 %, mean time to peak TSI was 213.6±10.9 ms; 1 month after PCI TSI improved significantly to 163.7±17.6 ms (pConclusion. Increased number and length of the implanted stents were predictors to non-improvement of mechanical dyssynchrony, while stent diameter didn’t affects the recovery.
- Open Access
- 18 July 2020
- Published by Elsevier in Indian Heart Journal
- Vol. 72 (4) , 265-271
Association of left atrial deformation indices with left atrial appendage thrombus in patients with non valvular atrial fibrillation
- 18 July 2020
- Published by Elsevier in Indian Heart Journal
- Vol. 72 (4) , 265-271
Open AccessAssociation of left atrial deformation indices with left atrial appendage thrombus in patients with non valvular atrial fibrillation
- Open Access
- 1 January 2020
- Published by Elsevier in Indian Heart Journal
- Vol. 72 (1) , 40-45
The predictive value of speckle tracking during dobutamine stress echocardiography in patients with chronic stable angina
- 1 January 2020
- Published by Elsevier in Indian Heart Journal
- Vol. 72 (1) , 40-45
Open AccessThe predictive value of speckle tracking during dobutamine stress echocardiography in patients with chronic stable angina
- Open Access
- 20 November 2019
- Published by Elsevier in Indian Heart Journal
- Vol. 71 (5) , 406-411
Assessment of right ventricular systolic function in heart failure with preserved, reduced and mid-range ejection fraction
- 20 November 2019
- Published by Elsevier in Indian Heart Journal
- Vol. 71 (5) , 406-411
Open AccessAssessment of right ventricular systolic function in heart failure with preserved, reduced and mid-range ejection fraction
- Open Access
- 11 September 2019
- Published by Springer Nature in The Egyptian Heart Journal
- Vol. 71 (1) , 1-7
Multi-slice CT coronary angiography assessment of remodeling index in patients with low- to intermediate-risk stable angina
Background: Early identification of vulnerable plaques by remodeling index prior to rupture and development of acute event is of considerable importance especially by a reliable non-invasive method as CT coronary angiography (CTA), so we aim to evaluate coronary artery remodeling index in patients with low- to intermediate-risk stable angina by CTA. Results: This single-center, cross-sectional, observational study included 150 patients with stable angina with normal resting ECG, negative markers, normal systolic function by 2D echocardiography (EF > 50%), and without regional wall motion abnormality at rest who were referred to MSCT evaluation of the coronary artery tree; the mean age was 56.8 ± 6.4 years, 83.3% had one-vessel disease, and 16.7% had two-vessel diseases. The mean remodeling index (RI) was 1.04 ± 0.28, 38% had significant positive remodeling, LAD was the most affected vessel (55.3), and proximal lesions were predominant in 48.5%; there was a statistically significant positive correlation between RI and cholesterol, triglyceride, LDL, duration of DM, HBA1c, and plaque burden (P < 0.001) and a statistically significant negative correlation with HDL (P < 0.001). Predictors of higher RI were positive family history, diabetes mellitus, low HDL, HBA1c, and plaque burden% (P < 0.001). Patients with remodeling index > 1.1 were diabetic, hypertensive, smoker, with longer duration of diabetes mellitus, higher HBA1c, cholesterol, triglyceride, LDL, plaque burden, wall lumen ratio, stenosis area, and lower HDL. Conclusion: CTA was able to detect the presence and extent of early, non-obstructive but significant coronary artery-positive remodeling in patients with low- to intermediate-risk stable angina patients. Trial registration: NCT03963609, 22 May 2019
- 11 September 2019
- Published by Springer Nature in The Egyptian Heart Journal
- Vol. 71 (1) , 1-7
Open AccessMulti-slice CT coronary angiography assessment of remodeling index in patients with low- to intermediate-risk stable angina
Background: Early identification of vulnerable plaques by remodeling index prior to rupture and development of acute event is of considerable importance especially by a reliable non-invasive method as CT coronary angiography (CTA), so we aim to evaluate coronary artery remodeling index in patients with low- to intermediate-risk stable angina by CTA. Results: This single-center, cross-sectional, observational study included 150 patients with stable angina with normal resting ECG, negative markers, normal systolic function by 2D echocardiography (EF > 50%), and without regional wall motion abnormality at rest who were referred to MSCT evaluation of the coronary artery tree; the mean age was 56.8 ± 6.4 years, 83.3% had one-vessel disease, and 16.7% had two-vessel diseases. The mean remodeling index (RI) was 1.04 ± 0.28, 38% had significant positive remodeling, LAD was the most affected vessel (55.3), and proximal lesions were predominant in 48.5%; there was a statistically significant positive correlation between RI and cholesterol, triglyceride, LDL, duration of DM, HBA1c, and plaque burden (P < 0.001) and a statistically significant negative correlation with HDL (P < 0.001). Predictors of higher RI were positive family history, diabetes mellitus, low HDL, HBA1c, and plaque burden% (P < 0.001). Patients with remodeling index > 1.1 were diabetic, hypertensive, smoker, with longer duration of diabetes mellitus, higher HBA1c, cholesterol, triglyceride, LDL, plaque burden, wall lumen ratio, stenosis area, and lower HDL. Conclusion: CTA was able to detect the presence and extent of early, non-obstructive but significant coronary artery-positive remodeling in patients with low- to intermediate-risk stable angina patients. Trial registration: NCT03963609, 22 May 2019
- Open Access
- 3 March 2019
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 15 (1) , 17-28-28
Comparison between Bolus Intracoronary versus Bolus Intravenous Injection Regimens of Eptifibatide during Primary Percutaneous Coronary Intervention in Patients with Anterior ST-Segment Elevation Myocardial Infarction
Background. Eptifibatide achieves high local concentration via direct intracoronary (I/V) injection as it promotes clot disaggregation, but it remains unclear if it is of superior benefit than the routine intravenous (I/V) administration. Aim. The current study aimed to examine the safety and efficacy of I/C vs I/V bolus regimen dose of eptifibatide during primary percutaneous coronary intervention (PPCI). Material and methods. Prospective, controlled, randomized study enrolled 100 patients with acute anterior ST-segment elevation myocardial infarction (STEMI) eligible for PPCI equally divided into 2 groups (group A received bolus I/C eptifibatide and group B received it I/V) followed by 12-hour continuous I/V infusion. Features related to of myocardial salvage in the form of TIMI flow grade 3, myocardial blush grade 3, ST segment resolution and left ventricular systolic function were evaluated with short-term follow up for 1 month. Results. Mean age of the study population was 50.95±8.45years, there was statistically insignificant difference between both groups regarding baseline characteristics in age (p=0.062), gender (p=0.488), coronary artery disease risk factors (p>0.05), time from onset of pain to admission (p=0.86) or door to balloon (p=0.12). Group A achieved statistically significant better myocardial blush grade 3 (42% vs 10%, p=0.005), ejection faction 30 days after PPCI (46.11±7.81% vs 40.88±6.26%, p=0.005) but statistically insignificant TIMI flow grade 3 (p=0.29) and ST resolution (p=0.34). Incidence of complications in the hospital and 30 days after discharge was statistically insignificant (p>0.05). Conclusion. Both regimens were safe and effective in STEMI patients undergoing PPCI and regimen of I/C bolus eptifibatide achieved better myocardial blush grade and systolic function.
- 3 March 2019
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 15 (1) , 17-28-28
Open AccessComparison between Bolus Intracoronary versus Bolus Intravenous Injection Regimens of Eptifibatide during Primary Percutaneous Coronary Intervention in Patients with Anterior ST-Segment Elevation Myocardial Infarction
Background. Eptifibatide achieves high local concentration via direct intracoronary (I/V) injection as it promotes clot disaggregation, but it remains unclear if it is of superior benefit than the routine intravenous (I/V) administration. Aim. The current study aimed to examine the safety and efficacy of I/C vs I/V bolus regimen dose of eptifibatide during primary percutaneous coronary intervention (PPCI). Material and methods. Prospective, controlled, randomized study enrolled 100 patients with acute anterior ST-segment elevation myocardial infarction (STEMI) eligible for PPCI equally divided into 2 groups (group A received bolus I/C eptifibatide and group B received it I/V) followed by 12-hour continuous I/V infusion. Features related to of myocardial salvage in the form of TIMI flow grade 3, myocardial blush grade 3, ST segment resolution and left ventricular systolic function were evaluated with short-term follow up for 1 month. Results. Mean age of the study population was 50.95±8.45years, there was statistically insignificant difference between both groups regarding baseline characteristics in age (p=0.062), gender (p=0.488), coronary artery disease risk factors (p>0.05), time from onset of pain to admission (p=0.86) or door to balloon (p=0.12). Group A achieved statistically significant better myocardial blush grade 3 (42% vs 10%, p=0.005), ejection faction 30 days after PPCI (46.11±7.81% vs 40.88±6.26%, p=0.005) but statistically insignificant TIMI flow grade 3 (p=0.29) and ST resolution (p=0.34). Incidence of complications in the hospital and 30 days after discharge was statistically insignificant (p>0.05). Conclusion. Both regimens were safe and effective in STEMI patients undergoing PPCI and regimen of I/C bolus eptifibatide achieved better myocardial blush grade and systolic function.
- Open Access
- 1 December 2018
- Published by Elsevier in Indian Heart Journal
- Vol. 70, S224-S228
Impact of obesity and surgical weight reduction on cardiac remodeling
- 1 December 2018
- Published by Elsevier in Indian Heart Journal
- Vol. 70, S224-S228
Open AccessImpact of obesity and surgical weight reduction on cardiac remodeling